	Perceived Feasibility and Acceptability of a Self-Collected HPV DNA Testing Policy for Cervical Cancer Screening in Thailand. J Prim Care Community Health Kositamongkol C, Mepramoon E, Kanchanasurakit S, Talungchit P, Chaopotong P, Kengkla K, Chaisathaphol T, Saokaew S, Phisalprapa P. PMID: 42693793 [PubMed - indexed for MEDLINE]
	HPV genotype distribution and associated risk factors in women from Karad, Maharashtra: A molecular characterisation study. Indian J Med Res Deshmukh VN, Patil SR, Hinge DD, Jadhav PS. PMID: 42690849 [PubMed - indexed for MEDLINE]
	Understanding the association between immune-modulating helminths and HPV or cervical cancer: A scoping review. PLoS Negl Trop Dis Frank A, Correa-Mendez M, Livinski AA, Duncan K, Clark EH, Gravitt PE. PMID: 42685064 [PubMed - indexed for MEDLINE]
	Assessing the Capacity of Health Facilities to Deliver Concomitant HPV Vaccination and HPV-Based Cervical Screening Services to Vulnerable Populations - An Implementation Research Protocol. Cancer Control Mosquera I, Tisler A, Ramirez AT, Elfstrom KM, Dillner J, Robles C, Peremiquel-Trillas P, Bosch X, Gini A, Baussano I, Bardou M, Hassine A, Franc C, Menvielle G, Tranberg M, Axelsen AL, Kirkegaard P, Andersen B, Petersen LK, Glintborg D, Martin-Iguacel R, Johansen IS, Christensen LL, Jespersen S, Hauge E, Rotar I, Muresan D, Baban A, Taut D, Redmond NM, Basu P. PMID: 42683830 [PubMed - indexed for MEDLINE]
	DNA Methylation Testing in Cervical Cancer: A Triage Tool for HPV-Based Screening and Post-Treatment Surveillance. J Obstet Gynaecol Res Xu Y, Zhou X, Guo L, Lyu R. PMID: 42681848 [PubMed - indexed for MEDLINE]
	Occurrence and relevance of Gardnerella vaginalis in urine cultures of kidney transplant recipients- a retrospective cohort analysis. BMC Microbiol Klein S, Deininger S, Schröter I, Nurjadi D, Sommerer C. PMID: 42681605 [PubMed - indexed for MEDLINE]
	Developments in human papillomavirus vaccines, schedules, and implementation strategies. J Natl Cancer Inst Monogr Bruni L, Brotons M, Alvarez J, Roden RBS. PMID: 42670627 [PubMed - indexed for MEDLINE]
	Benefits, harms, and cervical cancer elimination timing of human papillomavirus screening approaches tailored to birth cohort as a proxy for vaccination status in the United States: a comparative modeling study. J Natl Cancer Inst Monogr Simms KT, de Bondt D, Killen J, Sy S, Naslazi E, Regan MC, Burger EA, Kim JJ, Smith MA, de Kok IMCM, Canfell K. PMID: 42670626 [PubMed - indexed for MEDLINE]
	From evidence to practice: leveraging implementation science for transitioning to risk-adapted cervical cancer screening. J Natl Cancer Inst Monogr Adsul P, Adcock R. PMID: 42670625 [PubMed - indexed for MEDLINE]
	Cervical cancer screening in vaccinated populations: challenges and implications for low- and middle-income countries. J Natl Cancer Inst Monogr Almonte M, Tejada RA, Calderón A, Baena A. PMID: 42670624 [PubMed - indexed for MEDLINE]
	Deintensification of cervical cancer screening in the era of high human papillomavirus-vaccination coverage. J Natl Cancer Inst Monogr Bonde J, Castle PE. PMID: 42670623 [PubMed - indexed for MEDLINE]
	How to evaluate and select cervical screening and triage tests in vaccinated populations. J Natl Cancer Inst Monogr Wentzensen N, Arbyn M, Poljak M. PMID: 42670622 [PubMed - indexed for MEDLINE]
	How practically feasible is tailored screening for cervical cancer based on human papillomavirus vaccination status?: the role of data linkage and registers. J Natl Cancer Inst Monogr Basu P, Lucas E, Elfström KM. PMID: 42670621 [PubMed - indexed for MEDLINE]
	Effective communications to support risk-adapted cervical screening in human papillomavirus-vaccinated women: lessons learned and ways forward. J Natl Cancer Inst Monogr Waller J, Marlow L. PMID: 42670620 [PubMed - indexed for MEDLINE]
	The need to change cervical cancer screening in the post-human papillomavirus vaccination era: the interplay between disease prevalence and risk, test characteristics, and efficiency of screening programs. J Natl Cancer Inst Monogr El-Zein M, Franco EL. PMID: 42670619 [PubMed - indexed for MEDLINE]
	Evidence for type replacement as a consequence of vaccination and implications for cervical screening. J Natl Cancer Inst Monogr Gray P, Louvanto K. PMID: 42670618 [PubMed - indexed for MEDLINE]
	HPV52 predominates in cervical infections and precancerous lesions in Chongqing, China: a 6-year study linking genotypes to vaginal microecology. Front Public Health Li X, Fan X, Chai T, Hu L, Lu X, Ren S. PMID: 42666361 [PubMed - indexed for MEDLINE]
	Herpetic reactivation during radiotherapy treatment for gynaecological cancers-a retrospective observational study. Support Care Cancer Tom DC, Udayashankara AH, S N, F HNA, R J, Garg S, Raj JM. PMID: 42665708 [PubMed - indexed for MEDLINE]
	The impact of switching to tenofovir alafenamide on lipid profile and renal function in chronic hepatitis B: a retrospective cohort study. Eur J Gastroenterol Hepatol Gül Ö, Erzurum Çiçek Z, Bila S. PMID: 42664457 [PubMed - indexed for MEDLINE]
	Genotype distribution of high-risk and potential high-risk HPV types among women in different screening and clinic settings in Ghana and Kenya. PLoS One Kwesi-Maliepaard EM, Osea-Larbi JA, Nyamari CK, Alhassan Y, Sromani AK, Kotey VM, Darko S, Tackie R, Kiome R, Mohammed AM, Buadii E, Quaye EK, Akligoh H, Ibrahim BA, Kaba P, Amoako SF, Kotey E, Agyemang S, Ngoi JM, Paemka L, Darkwa K, Degley T, Siebu NE, Olwal CO, Morang'a CM, Manu A, Hutchful D, Amoako E, Onyambu FG, Bediako Y. PMID: 42664253 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 27478

Page 1 of 1374



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy